Ovalbumin lipid core peptide vaccines and their CD4+ and CD8+ T cell responses

Vaccine

Volumn 32, Issue 37, 2014, Pages 4743-4750

  Simerska, Pavla ^a   Suksamran, Tittaya ^a   Ziora, Zyta Maria ^a   Rivera, Fabian de Labastida ^b   Engwerda, Christian ^b   Toth, Istvan ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Ovalbumin; Peptide synthesis; T cell; Vaccine development

Indexed keywords

LIPID; OVALBUMIN; OVALBUMIN LIPID CORE PEPTIDE VACCINE; PEPTIDE VACCINE; UNCLASSIFIED DRUG; SUBUNIT VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; HEMOLYSIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; T LYMPHOCYTE ACTIVATION; VACCINE PRODUCTION; ANIMAL; C57BL MOUSE; CHEMISTRY; DRUG EFFECTS; ERYTHROCYTE; IMMUNOLOGY; SYNTHESIS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ERYTHROCYTES; FEMALE; HEMOLYSIS; HUMANS; MICE; MICE, INBRED C57BL; OVALBUMIN; VACCINES, SUBUNIT;

EID: 84905226673     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.06.049     Document Type: Article

References (27)

1. Simerska P., Moyle P.M., Toth I. Modern lipid-, carbohydrate-, and peptide-based delivery systems for peptide, vaccine, and gene products. Med Res Rev 2011, 31(4):520-547.
2. Moyle P.M., Toth I. Self-adjuvanting lipopeptide vaccines. Curr Med Chem 2008, 15(5):506-516.
3. Schreiber R.D., Old L.J., Smyth M.J. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011, 331(6024):1565-1570.
4. Sato E., Olson S.H., Ahn J., Bundy B., Nishikawa H., Qian F., et al. Intraepithelial CD8(+) tumor-infiltrating lymphocytes and a high CD8(+)/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A 2005, 102(51):18538-18543.
5. Kantoff P.W., Higano C.S., Shore N.D., Berger E.R., Small E.J., Penson D.F., et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 2010, 363(5):411-422.
6. Frazer I.H., Leggatt G.R., Mattarollo S.R. Prevention and treatment of papillomavirus-related cancers through immunization. Annu Rev Immunol 2011, 29:111-138.
7. Di Genova G., Savelyeva N., Suchacki A., Thirdborough S.M., Stevenson F.K. Bystander stimulation of activated CD4(+) T cells of unrelated specificity following a booster vaccination with tetanus toxoid. Eur J Immunol 2010, 40(4):976-985.
8. Mayer S., Laumer M., Mackensen A., Andreesen R., Krause S.W. Analysis of the immune response against tetanus toxoid: enumeration of specific T helper cells by the Elispot assay. Immunobiology 2002, 205(3):282-289.
9. Sabarth N., Chamberlain L., Brett S., Tite J., Craigen J. Induction of homologous rather than heterologous antigen-specific CD4T cell responses is critical for functional CD8T cell responses in mice transgenic for a foreign antigen. J Immunol 2010, 185(8):4590-4601.
10. Burgdorf S., Kautz A., Bohnert V., Knolle P.A., Kurts C. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8T cell activation. Science 2007, 316(5824):612-616.
11. Platt C.D., Ma J.K., Chalouni C., Ebersold M., Bou-Reslan H., Carano R.A., et al. Mature dendritic cells use endocytic receptors to capture and present antigens. Proc Natl Acad Sci U S A 2010, 107(9):4287-4292.
12. Lipford G.B., Hoffman M., Wagner H., Heeg K. Primary in vivo responses to ovalbumin-probing the predictive value of the Kb binding motif. J Immunol 1993, 150(4):1212-1222.
13. Szymczak-Workman A.L., Workman C.J., Vignali D.A.A. Cutting edge: regulatory T cells do not require stimulation through their TCR to suppress. J Immunol 2009, 182(9):5188-5192.
14. Hogquist K.A., Jameson S.C., Heath W.R., Howard J.L., Bevan M.J., Carbone F.R. T-cell receptor antagonist peptides induce positive selection. Cell 1994, 76(1):17-27.
15. Barnden M.J., Allison J., Heath W.R., Carbone F.R. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol 1998, 76(1):34-40.
16. Stanley A.C., Dalton J.E., Rossotti S.H., MacDonald K.P., Zhou Y.H., Rivera F., et al. VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis. PLOS Pathog 2008, 4. (9).
17. Amin K., Dannenfelser R.M. In vitro hemolysis: guidance for the pharmaceutical scientist. J Pharm Sci 2006, 95(6):1173-1176.
18. Collins J.M., Leadbeater N.E. Microwave energy: a versatile tool for the biosciences. Org Biomol Chem 2007, 5(8):1141-1150.
19. Miranda L.P., Jones A., Meutermans W.D.F., Alewood P.F. P-cresol as a reversible acylium ion scavenger in solid-phase peptide synthesis. J Am Chem Soc 1998, 120(7):1410-1420.
20. Pennington M.W. HF cleavage and deprotection procedures for peptides synthesized using a Boc/Bzl strategy. Methods Mol Biol 1994, 35:41-62.
21. Zhang N., Bevan M.J. CD8(+) T Cells: foot soldiers of the immune system. Immunity 2011, 35(2):161-168.
22. Hou S., Hyland L., Ryan K.W., Portner A., Doherty P.C. Virus-specific Cd8+ T-cell memory determined by clonal burst size. Nature 1994, 369(6482):652-654.
23. Vijh S., Pamer E.G. Immunodominant and subdominant CTL responses to Listeria monocytogenes infection. J Immunol 1997, 158(7):3366-3371.
24. Murali-Krishna K., Altman J.D., Suresh M., Sourdive D.J.D., Zajac A.J., Miller J.D., et al. Counting antigen-specific CD8T cells: a reevaluation of bystander activation during viral infection. Immunity 1998, 8(2):177-187.
25. Busch D.H., Pilip I.M., Vijh S., Pamer E.G. Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 1998, 8(3):353-362.
26. Shortman K., Heath W.R. The CD8 + dendritic cell subset. Immunol Rev 2010, 234:18-31.
27. Dudziak D., Kamphorst A.O., Heidkamp G.F., Buchholz V.R., Trumpfheller C., Yamazaki S., et al. Differential antigen processing by dendritic cell subsets in vivo. Science 2007, 315(5808):107-111.